Blood
Sugar Levels for People on Antidiabetic Prescription Medications
Released on
= September 14, 2005, 4:14 am
Press Release
Author = www.nutrition21.com
Industry = Healthcare
Press Release
Summary = : Www.nutrition21.comis a leading developer of nutritional
products for cardiovascular health and diabetes;The market leader
in nutritional chromium, Www.nutrition21.comcurrently holds 35 patents
for nutrition products, 22 for chromium compounds and their uses.
(Nutrition 21, Nutrition twenty-one, nutritional products, nutrition
supplements, chromium picolinate, chromium, dietary supplement,
weight management, cardiovascular health, diabetes, developer, manufacturer,
research)
Press Release
Body = Www.nutrition21.com(NASDAQ: NXXI) — A sub-set analysis
from a Diachrome XLHealth clinical trial demonstrates
that adding daily supplementation with Diachrome to prescription
treatment regimens can significantly improve glycemic control in
poorly controlled blood sugar levels in people with type
2 diabetes. The results of this study conducted in collaboration
with XLHealth, a U.S. based and U.S. nationally recognized disease
management firm handling chronically ill patients for the Centers
for Medicare and Medicaid Services (CMS), were presented today at
the 41st Annual Meeting of the European Association for the Study
of Diabetes in Athens, Greece. The randomized, double-blind, placebo-controlled,
multi-center 12-week study was designed to examine the efficacy
of Diachrome as an adjunct to medications in 369 patients with type
2 diabetes. This analysis of the trial looked specifically at 60
patients who had HbA1c ≥ 10% and were taking one or more
oral antidiabetic medication, including: sulfonylureas, biguanides,
and thiazolidinediones. Study participants taking Diachrome with
one or more antidiabetic medication saw an
average range of 0.7 – 1.9% point reduction in HbA1c levels.
The study also showed that insulin resistance was significantly
reduced (P<0.05) in those taking thiazolidinediones and Diachrome.
There were no adverse reports of hypoglycemia in these patients. “Diachrome’s impact in the more severe diabetes
cases is positive, as these patients can be the hardest to control
and are more likely to develop debilitating and costly disease-related
health complications such as amputation and heart disease,”
said Paul Serini, executive vice president of XLHealth. “Given
the high cost of diabetes care, those of us involved in the delivery
of
healthcare should look carefully at complementary, cost-effective
nutritional therapies, like Diachrome, and their potential benefits
for patients and third-party payors."
(more)
/2
Www.nutrition21.com(NXXI: Nasdaq), the maker of Diachrome, and XLHealth
recently announced an agreement to make Diachrome available to physicians
participating in the Center for Medicare and Medicaid (CMS) sponsored-Medicare
Health Support program
(formerly known as the Chronic Care Improvement Program) in Tennessee.
XLHealth’s Medicare Health Support program, created by
U.S. Congress as part of the 2003 Medicare Modernization Act, will
begin to address the need for diabetes management by reaching out
to 20,000 Medicare patients in Tennessee who are living
with diabetes and heart failure. “We are confident that
these new scientific findings and the treatment success that will
be seen in the XLHealth Medicare Health Support program will fuel
further
adoption of Diachrome in diabetes care,” said Gail Montgomery,
president and CEO of Nutrition 21.
The Economic
Toll of Diabetes
At least 171 million people worldwide have diabetes. The World Health
Organization (WHO) estimates that anywhere from 2.5% to 15% of healthcare
budgets are spent on diabetes-related illnesses depending on local
diabetes prevalence and the sophistication of the treatment available.
Findings from the Diabetes Control and
Complications Trial, a 10-year clinical trial conducted by the National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
indicate that a low-cost intervention that decreases HbA1c could
be beneficial to patients, third party payors and society as a whole.
A recent economic analysis conducted by Thomas Jefferson University
and published in the August 2005 issue of the publication Disease
Management, demonstrated that daily use of Diachrome in addition
to traditional anti-diabetic medications could deliver a potential
average three-year cost savings of up to $52.9 billion for patients
within the United States already diagnosed with diabetes, plus a
lifetime cost
savings of $42 billion for newly diagnosed patients annually as
a result of the therapy’s effect on HbA1c. Diachrome is
a nutritional supplement specifically formulated for people with
diabetes. It contains 600 mcg of chromium as Chromax® chromium
picolinate and 2 mg of biotin. These two compounds are both Generally
Recognized as Safe (GRAS) for use as ingredients in food and supplements.
Diachrome can be obtained through diabetes
educators nationwide, or can be purchased directly at http://www.diachrome.com
or by calling 1-866-DIACHROME.
Web Site = http://www.nutrition21.com
Contact Details
= nutrition21
4 Manhattanville Road
Purchase , New York 10577
contactn21@nutrition21.com
Main 914-701-4500
IR 914-701-4545
Fax 914-696-0860
Mail: dannoyes2005@yahoo.com
url: www.nutrition21.com
Printer
Friendly Format
Back
to previous page...
Back
to home page...
Submit
your press releases...
|
2022
